相关实验视频

Updated: May 9, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

在ST段升高心肌梗塞患者心脏康复后指导风险分层的NT-proBNP

Nerea Pérez-Solé¹, Elena de Dios², José Gavara¹

¹Instituto de Investigación Sanitaria INCLIVA, Valencia, , España; Centro de Investigación Biomédica en Red - Cardiovascular (CIBER-CV), Madrid, España.

European journal of internal medicine

|May 2, 2025

概括

在心脏康复后的ST段升高心肌梗塞 (STEMI) 患者中,N终端前脑尿素 (NT-proBNP) 能够有效预测主要心脏不良事件 (MACE). 较高的NT-proBNP水平表明MACE的风险较高,有助于患者风险分层.

科学领域:

心脏病学心脏病学
生物标志物研究生物标志物研究
临床风险分层的临床风险分层

背景情况:

在STEMI和心脏康复后NT-proBNP的预后价值尚未确定.
心脏康复对于STEMI恢复至关重要.
在STEMI之后需要可访问的风险分层工具.

研究的目的:

在STEMI后评估NT-proBNP的预后意义.
为了确定NT-proBNP是否预测MACE心脏病后康复.
评估NT-proBNP在STEMI患者风险分层中的作用.

主要方法:

在心脏康复后的STEMI患者的探索和验证队列.
在STEMI后45天的中位数测量NT-proBNP水平.
主要终点:主要心脏不良事件 (MACE),包括心脏死亡,心肌梗塞或心力衰竭再入院.
收集了基线和CMR成像数据.

主要成果:

在探索组中,NT-proBNP>400 pg/mL预测了MACE (HR 6.8,p=0.01).
在研究组 (随访203周),NT-proBNP>400 pg/mL与更高的MACE率相关 (46%对10%,HR 4.6,p<0.001).
NT-proBNP改善了MACE预测模型 (AUC 0.81与0.72,p<0.001) 并确定了心脏死亡,心脏病发作和HF再入院的风险增加.

结论:

在心脏康复后的STEMI患者中,NT-proBNP是MACE的强有力的预测剂.
NT-proBNP 作为一个可访问和廉价的风险分层工具.
较高的NT-proBNP水平需要对STEMI幸存者进行更密切的监测和潜在的干预.

关键词:

心血管磁共振是一种心血管磁共振.在 N-终端的前脑 natriuretic .预测预后预测预测康复康复康复康复 St段升高心肌梗塞的心肌梗塞

更多相关视频

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

相关概念视频

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...